Egide: The Group enters into a financing agreement with Amerisource Business Capital for its US entities

Bollène, December 28, 202206 :00pm (CET)
Press Release

The Group enters into a financing agreement with Amerisource Business Capital for its US entities

Egide Group (Euronext Growth Paris™- ISIN: FR0000072373 – Mnemo: ALGID) and Amerisource Business Capital, a direct lender and capital provider to growing businesses throughout the United States and one of the largest independent finance American companies, today announced the signing of a $3M financing agreement.

This asset-based financing (ABL) who finances Egide USA and Santier at 1,5M$ each based on the Accounts Receivable and Inventories of each entity.

Amerisource Business Capital has used the new financing of 3M$ to repay the Lines of Credit and Remaining Long Term Loans to Bank of California for a total amount of 2.66M$.

Combined with the $6 million sale/leaseback of the Cambridge (MS, USA) building, Egide now has a clean financial position that allows it to focus on following its growth strategy in its existing and future markets.


2022 full year sales January 26, 2023


EGIDE – Luc ArdonCFO – +33 4 90 30 35 94 – [email protected]

FIN’EXTENSO – Press Relations – Isabelle Aprile – +33 1 39 97 61 22 – [email protected]

About Egide –

Egide is a group with an international dimension, specialized in the manufacture of hermetic packages and heat dissipation solutions for sensitive electronic components. It operates in cutting edge markets with strong technology barriers to entry in all critical industry segments (Thermal Imaging. Optronics. High-Frequency. Power Units…). Egide is the only pure player in this market niche with manufacturing bases in France and the United States.

EGIDE is listed Euronext Growth Paris™- ISIN : FR0000072373 – Mnémo : ALGID

Keep up to date with all the Group’s news online: and LinkedIn


  • Egide-PR-Amerisource-EN-221228

Disclaimer: The above press release comes to you under an arrangement with GlobeNewswire. takes no editorial responsibility for the same.